Abstract:Objective To research the expression,methylated regulation and clinical significances of miR-34b in chidren with acute leukemia(AL).Methods The methylation status of miR-34b promoter CpG islands were detected with methylation-specific polymerase chain reaction (MSP) in patients with AL.Then the expression of miR-34b was compared,which was detected by Taqman real-time fluorescence quantitative polymerase chain reaction (qRT-PCR),between the AL patients and normal group,in order to analyze their relationship with the clinical indicators.Resuits In 8 leukemia cell lines (U937,HL-60,MV4-11,M2R,K562,Raji,CCRF,DAMI) showed methylation,the positive rate of the methyl was 100％.Thirty-one acute lymphocytic leukemia(ALL) pediatric patients were newly diagnosed,and 24 cases showed methylation,the methylation positive rate 77.42％ (24/31).Nineteen acute myeloid leukemia(AML) patients were newly diagnosed,and 8 cases showed methylation,the methylation positive rate was 42.11％ (8/19 cases).There was no methylation in the 23 cases of normal children.The relative expression levels of miR-34b in the normal group,the group of leukemia cell lines,the group of ALL pediatric patients with newly diagnosed,the AML group and the group with mixed lineage leukemia gene rearrangement MLL+ were 5.22 ± 1.15,0.03 ± 0.03,1.65 ± 0.69,0.18 ± 0.06,0.64 ± 0.34,respectively.The findings indicated that there were significant differences in the relative expression levels of miR-34b between the normal group and the group of leukemia cell lines,the ALL group,the AML group,and the MLL+ group.The relative expression and methylated level of miR-34b had no statistically difference in gender,age at diagnosis,WBC count,chromosome,fusion gene,MLL gene rearrangement,and the minimal residual disease(LDH) levels in newly diagnosed AML patients(all P ＞ 0.05).And the relative expression and methylated level of miR-34b had no statistically difference in gender,age at diagnosis,WBC count,immunophenotype,chromosome,fusion gene,MLL gene rearrangement,TEL/AML1 gene,risk stratification,the minimal residual disease (MRD) in thirty-three days and the LDH levels in newly diagnosed ALL patients(all P ＞ 0.05).But as for the response to prednisone experiment,there was a significant difference between the sensitive group and the non sensitive group(P ＜ 0.05).Conclusions The expression level of miR-34b in AL was significantly lower and it was regulated by methylation mechanism,which implies that miR-34b may play a role of a tumor suppressor gene in the pathogenesis of leukemia.MiR-34b may affect the early treatment response of ALL patients,and it may be an indicator of risk stratification and poor prognosis in pediatric ALL.

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF MIR-203 IN PEDIATRIC ACUTE LEUKEMIA

MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia.

Expression and clinical significance of miR-34b in children with acute leukemia

MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.

Expression Characteristics and Prognosissignificance of Mirna-181A in Acute Myeloid Leukemia with Normal Karyotype

MiR-362-5p As a Novel Prognostic Predictor of Cytogenetically Normal Acute Myeloid Leukemia

Clinical Significance of Microrna-34b Expression in Pediatric Acute Leukemia

Downregulation of Mir-142 Promotes Leukemia Growth in Philadelphia Chromosome-Positive (ph+) Acute Lymphoblastic Leukemia (ALL): A Possible Novel Therapeutic Target?

Correlation of Plasma MiR-146a,MiR-223 Levels with the Prognosis of Childhood with Acute Lymphoblastic Leukemia

The expressions of miR-196b and its prognostic significances in pediatric acute myeloid leukemia

High Level Of Mir-196b At Newly Diagnosed Pediatric Acute Myeloid Leukemia Predicts A Poor Outcome

The Expressions and Significances of Mir-155 in 52 Bone Marrow Samples of Preliminary Pediatric Acute Myeloid Leukemia

Microrna Patterns Associated With Clinical Prognostic Parameters And Cns Relapse Prediction In Pediatric Acute Leukemia

Expression pattern of <i>miR-16-2-3p</i> and its prognostic values on pediatric acute lymphoblastic leukemia

High Expression of Mir-25 Predicts Favorable Chemotherapy Outcome in Patients with Acute Myeloid Leukemia.

The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)

Overexpressed Mir-155 is Associated with Initial Presentation and Poor Outcome in Chinese Pediatric Acute Myeloid Leukemia.

Expression and significance of micro RNA-103b in patients with acute lymphoblastic leukemia

Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia

Mir-99a May Serve As A Potential Oncogene in Pediatric Myeloid Leukemia

Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.